Skip to main content
letter
. 2021 Apr 13;27(7):1129–1130. doi: 10.1016/j.jiac.2021.04.003

Table 1.

Comparison of ESPLINE® SARS-CoV-2 data vs molecular reference test (Simplexa™ COVID-19 Direct assay) on saliva samples.



ESPLINE® SARS-CoV-2

Positive Negative Total
Simplexa™ COVID-19 Direct Positive 5 57 62
Negative 0 74 74
Total 5 131 136
Proportion# Percentage (95% CI)
Sensitivity 5/62 8.1% (2.7% - 17.8%)
Specificity vs RT-PCR reference test 74/74 100.0% (95.1% - 100.0%)